CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

A stretch of viral DNA in the mouse genome gives cells in early-stage embryos the potential to become almost any cell type in ...

Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

As we age, we don't recover from injury or illness like we did when we were young. But new research from UCSF has found gene ...

Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...

University of New Mexico researchers found that the immune enzyme OTULIN drives tau production, brain inflammation and aging.

A newly discovered genetic form of neonatal diabetes shows how a single gene defect shuts down insulin production in newborns ...

Basecamp Research, a frontier AI lab harnessing evolution to design new medicines, today announced the first AI models capable of programmable gene insertion, offering a new way to replace faulty ...